These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10773093)

  • 1. Antisense delivery using protamine-oligonucleotide particles.
    Junghans M; Kreuter J; Zimmer A
    Nucleic Acids Res; 2000 May; 28(10):E45. PubMed ID: 10773093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides.
    Junghans M; Loitsch SM; Steiniger SC; Kreuter J; Zimmer A
    Eur J Pharm Biopharm; 2005 Jul; 60(2):287-94. PubMed ID: 15939239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization.
    Lochmann D; Weyermann J; Georgens C; Prassl R; Zimmer A
    Eur J Pharm Biopharm; 2005 Apr; 59(3):419-29. PubMed ID: 15760722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antisense oligonucleotide drug delivery systems.
    Weyermann J; Lochmann D; Zimmer A
    J Control Release; 2004 Dec; 100(3):411-23. PubMed ID: 15567506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.
    Scheicher B; Schachner-Nedherer AL; Zimmer A
    Eur J Pharm Sci; 2015 Jul; 75():54-9. PubMed ID: 25896372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of complexes of an antisense oligonucleotide with protamine and poly-L-lysine salts.
    González Ferreiro M; Tillman L; Hardee G; Bodmeier R
    J Control Release; 2001 Jun; 73(2-3):381-90. PubMed ID: 11516513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.
    Weyermann J; Lochmann D; Georgens C; Zimmer A
    Eur J Pharm Biopharm; 2005 Apr; 59(3):431-8. PubMed ID: 15760723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles.
    Junghans M; Kreuter J; Zimmer A
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):177-88. PubMed ID: 11341927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.
    Vogel V; Lochmann D; Weyermann J; Mayer G; Tziatzios C; van den Broek JA; Haase W; Wouters D; Schubert US; Kreuter J; Zimmer A; Schubert D
    J Control Release; 2005 Mar; 103(1):99-111. PubMed ID: 15710504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration.
    Scheicher B; Lorenzer C; Gegenbauer K; Partlic J; Andreae F; Kirsch AH; Rosenkranz AR; Werzer O; Zimmer A
    PLoS One; 2016; 11(11):e0164149. PubMed ID: 27828968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
    Ollikainen H; Lappalainen K; Jääskeläinen I; Syrjänen S; Pulkki K
    Leuk Lymphoma; 1996 Dec; 24(1-2):165-74. PubMed ID: 9049973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice.
    Pali-Schöll I; Szöllösi H; Starkl P; Scheicher B; Stremnitzer C; Hofmeister A; Roth-Walter F; Lukschal A; Diesner SC; Zimmer A; Jensen-Jarolim E
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):656-64. PubMed ID: 23523543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
    Dinauer N; Lochmann D; Demirhan I; Bouazzaoui A; Zimmer A; Chandra A; Kreuter J; von Briesen H
    J Control Release; 2004 May; 96(3):497-507. PubMed ID: 15120905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
    Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
    Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
    Mayer G; Vogel V; Weyermann J; Lochmann D; van den Broek JA; Tziatzios C; Haase W; Wouters D; Schubert US; Zimmer A; Kreuter J; Schubert D
    J Control Release; 2005 Aug; 106(1-2):181-7. PubMed ID: 16002173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
    Biro S; Fu YM; Yu ZX; Epstein SE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.